References
- Grabowski GA . Phenotype, diagnosis, and treatment of Gaucher‘s disease. Lancet372(9645), 1263–1271 (2008).
- Van Der Ploeg AT , ReuserAJ. Pompe‘s disease. Lancet372(9646), 1342–1353 (2008).
- Zarate YA , HopkinRJ. Fabry‘s disease. Lancet372(9647), 1427–1435 (2008).
- Grabowski GA , HopkinRJ. Enzyme therapy for lysosomal storage disease: principles, practice, and prospects. Ann. Rev. Genomics Hum. Genet.4, 403–436 (2003).
- Jmoudiak M , FutermanAH. Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol.129(2), 178–188 (2005).
- Naito M , TakahashiK, HojoH. An ultrastructural and experimental study on the development of tubular structures in the lysosomes of Gaucher cells. Lab. Invest.58(5), 590–598 (1988).
- Bussink AP , Van Eijk M, Renkema GH, Aerts JM, Boot RG. The biology of the Gaucher cell: the cradle of human chitinases. In: International Review of Cytology. Kwang WJ (Ed.). Academic Press, TN, USA, 71–128 (2006).
- Piran S , AmatoD. Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment. J. Inherit. Metab. Dis.33(3), 271–279 (2010).
- Elstein D , CohnGM, WangN, DjordjevicM, BrutaruC, ZimranA. Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease. Blood Cells Mol. Dis.46(1), 119–123 (2011).
- Lachmann RH . Enzyme replacement therapy for lysosomal storage diseases. Curr. Opin. Pediatr.23(6), 588–593 (2011).
- Connock M , BurlsA, FrewEet al. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher‘s disease: a systematic review. Health Technol. Assess. 10(24), iii–iv, ix-136 (2006).
- Gregoriadis G . Liposomes in the therapy of lysosomal storage diseases. Nature275(5682), 695–696 (1978).
- Gregoriadis D , LouisL, NeerunjunD. Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. Biochem. J.140(2), 323–330 (1974).
- Patel HM , RymanBE. Alpha-mannosidase in zinc-deficient rats. Possibility of liposomal therapy in mannosidosis. Bioch. Soc. Trans.2, 1014–1017 (1974).
- Steger LD , DesnickRJ. Enzyme therapy. VI: comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. Biochim. Biophys. Acta464(3), 530–546 (1977).
- Braidman IP , GregoriadisG. Rapid partial-purification of placental glucocerebroside β-glucosidase and its entrapment in liposomes. Biochem. J.164(2), 439–445 (1977).
- Umezawa F , EtoY, TokoroT, ItoF, Maekawa,K. Enzyme replacement with liposomes containing beta-galactosidase from Charonia lumpas in murine globoid cell leukodystrophy (twitcher). Biochem. Biophys. Res. Commun.127(2), 663–667 (1985).
- Koshkaryev A , ThekkedathR, PaganoC, MeerovichI, TorchilinVP. Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B. J. Drug Target19(8), 606–614 (2011).
- Newburg DS , SheaTB, YatzivS, RaghavanSS, McCluerRH. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells. Exp. Mol. Pathol.48, 317–323 (1988).
- Das PK , MurrayGJ, GalAE, BarrangerJA. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages. Exp. Cell. Res.168(2), 463–474 (1987).
- Yatziv S , NewburgDS, LivniN, BarfiG, KolodnyEH. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition. J. Lab. Clin. Med.111(4), 416–420 (1988).
- Meerovich I , KoshkaryevA, ThekkedathR, TorchilinVP. Screening and optimization of ligand conjugates for lysosomal targeting. Bioconjug. Chem.22(11), 2271–2282 (2011).
- Daigneault M , PrestonJA, MarriottHM, WhyteMK, DockrellDH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE5(1), e8668 (2010).
- Luzio JP , PryorPR, BrightNA. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol.8(8), 622–632 (2007).
- Huth U , WieschollekA, GariniY, SchubertR, Peschka-SussR. Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes. Cytometry A57(1), 10–21 (2004).
- Schnyder A , HuwylerJ. Drug transport to brain with targeted liposomes. NeuroRx2(1), 99–107 (2005).
- Sou K , GoinsB, OyajobiBO, TraviBL, PhillipsWT. Bone marrow-targeted liposomal carriers. Expert Opin. Drug Deliv.8(3), 317–328 (2011).